Bausch Health Companies (BHC) Stock Price, News & Analysis

Company Overview

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.

Key Stats

• Today's Range: C$9.28 to C$9.66
• 50-Day Range: C$7.89 to C$11.52
• 52-Week Range: C$5.91 to C$13.74
• Volume: 398,365 shs
• Average Volume: 377,479 shs
• Market Capitalization: C$3.48 billion
• P/E Ratio: 36.15
• Dividend Yield: 0.76%
• Price Target: N/A
• Consensus Rating: Hold

BHC Stock Analysis - Frequently Asked Questions

How have BHC shares performed this year?

Bausch Health Companies' stock was trading at C$11.62 on January 1st, 2025. Since then, BHC stock has decreased by 17.6% and is now trading at C$9.57.

How do I buy shares of Bausch Health Companies?

Shares of BHC stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Bausch Health Companies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Bausch Health Companies investors own include Chesapeake Energy (CHKAQ), Meta Platforms (META), Advanced Micro Devices (AMD), Enbridge (ENB), Shopify (SHOP), NVIDIA (NVDA) and Ford Motor (F).

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Pharmaceutical Products
• Current Symbol: TSE:BHC
• CIK: N/A
• Web: www.valeant.com
• Phone: 514-744-6792
• Fax: N/A
• Employees: 19,900
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): C$0.26
• Trailing P/E Ratio: 35.81
• Forward P/E Ratio: 1.68
• P/E Growth: 0.21
• Net Income: -C$125.65 million
• Net Margins: -1.88%
• Pretax Margin: N/A
• Return on Equity: 15.87%
• Return on Assets: 4.16%

Debt

• Debt-to-Equity Ratio: -1,831.94
• Current Ratio: 1.19
• Quick Ratio: 0.58

Sales & Book Value

• Annual Sales: C$9.86 billion
• Price / Sales: 0.35
• Cash Flow: C$1.20 per share
• Price / Cash Flow: 7.76
• Book Value: C($0.66) per share
• Price / Book: -14.17

Miscellaneous

• Outstanding Shares: 369,790,000
• Free Float: N/A
• Market Cap: C$3.44 billion
• Optionable: Not Optionable
• Beta: 0.48